Literature DB >> 8314507

Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17.

G Mulholland1, J E Ardill, D Fillmore, R S Chittajallu, G M Fullarton, K E McColl.   

Abstract

Helicobacter pylori infection increases the serum concentration of gastrin, and this may be one of the mechanisms by which it predisposes to duodenal ulceration. Different forms of circulating gastrin were studied both basally and postprandially in 13 duodenal ulcer patients before and one month after eradication of H pylori. Three antisera that are specific for particular regions of the gastrin molecules were used. Gel chromatography indicated that > 90% of the circulating gastrin consisted of gastrin (G) 17 and G34 both before and after eradicating the infection. The basal median total immunoreactive gastrin concentration fell from 26 pmol/l (range 11-43) to 19 pmol/l (8-39) (p < 0.05), entirely because of a fall in G17 from 6 pmol/l (< 2.4-25) to < 2.4 pmol/l (< 2.4-23) (p < 0.001). The median (range) basal G34 values were similar before (15 pmol (2-36)) and after (10 pmol (2-30)) eradication. The median total immunoreactive gastrin concentration determined 20 minutes postprandially fell from 59 pmol/l (38-114) to 33 pmol/l (19-88) (p < 0.005), and again this was entirely the result of a fall in G17 from 43 pmol/l (9-95) to 17 pmol/l (< 2.4-52) (p < 0.001). The median postprandial G34 values were similar before (13 pmol/l, range 6-42) and after (15 pmol/l, range 6-30) eradication. Eating stimulated a noticeable rise in G17 but little change in G34, both in the presence and absence of H pylori. The finding that H pylori infection selectively increases G17 explains why the infection causes mainly postprandial hypergastrinaemia. G17 is increased selectively because H pylori predominantly affects the antral mucosa which is the main source of G17 whereas G34 is mainly duodenal in origin. This study also indicates that the increased concentration of gastrin in H pylori infection is the result of an increase in one of the main biologically active forms of the hormone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314507      PMCID: PMC1374257          DOI: 10.1136/gut.34.6.757

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  THE CONSTITUTION AND PROPERTIES OF TWO GASTRINS EXTRACTED FROM HOG ANTRAL MUCOSA.

Authors:  R A GREGORY; H J TRACY
Journal:  Gut       Date:  1964-04       Impact factor: 23.059

2.  NH2-terminal of gastrin-17 in duodenal ulcer disease: identification of progastrin-17.

Authors:  P C Kothary; A I Vinik
Journal:  Biochem Biophys Res Commun       Date:  1987-07-31       Impact factor: 3.575

3.  Evidence that gastrin 34 is preferentially released from the human duodenum.

Authors:  C B Lamers; J H Walsh; J B Jansen; A R Harrison; A F Ippoliti; J H van Tongere
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

4.  Effect of a Campylobacter pylori protein on acid secretion by parietal cells.

Authors:  D R Cave; M Vargas
Journal:  Lancet       Date:  1989-07-22       Impact factor: 79.321

5.  Campylobacter pylori and duodenal ulcers: the gastrin link.

Authors:  S Levi; K Beardshall; G Haddad; R Playford; P Ghosh; J Calam
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

6.  Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels.

Authors:  G Oderda; D Vaira; J Holton; C Ainley; F Altare; N Ansaldi
Journal:  Lancet       Date:  1989-04-01       Impact factor: 79.321

7.  Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori.

Authors:  J T Smith; R E Pounder; C U Nwokolo; S Lanzon-Miller; D G Evans; D Y Graham; D J Evans
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

8.  Abnormal processing of antral gastrin in active duodenal ulcer disease.

Authors:  B Petersen; B N Andersen
Journal:  Eur J Clin Invest       Date:  1984-06       Impact factor: 4.686

9.  Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection.

Authors:  D Y Graham; A Opekun; G M Lew; D J Evans; P D Klein; D G Evans
Journal:  Am J Gastroenterol       Date:  1990-04       Impact factor: 10.864

10.  Postprandial changes in serum concentrations of gastrin-17, gastrin-34, and total gastrin in patients with duodenal or gastric ulcers and in normal subjects.

Authors:  K Walker; B Pinchbeck; V Mahachai; I Simpson; P Kirdeikis; L Zuk; K Brunet; R Sherbaniuk; L Chitnuyanondh; R Cherry
Journal:  Clin Ther       Date:  1985       Impact factor: 3.393

View more
  16 in total

1.  Low circulating levels of gastrin-17 in patients with Barrett's esophagus.

Authors:  Pentti Sipponen; Matti Vauhkonen; Timo Helske; Ilpo Kaariainen; Matti Harkonen
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

Review 2.  Role of gastrin-peptides in Barrett's and colorectal carcinogenesis.

Authors:  Eduardo Chueca; Angel Lanas; Elena Piazuelo
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

3.  Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4.

Authors:  Leisa Mandell; Anthony P Moran; Andrew Cocchiarella; JeanMarie Houghton; Nancy Taylor; James G Fox; Timothy C Wang; Evelyn A Kurt-Jones
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

4.  Expression of progastrin-derived peptides and somatostatin in fundus and antrum of nonulcer dyspepsia subjects with and without Helicobacter pylori infection.

Authors:  Y Zavros; A Paterson; J Lambert; A Shulkes
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

5.  Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy.

Authors:  M Pérez-Paramo; A Albillos; J L Calleja; C Salas; M C Marín; M L Marcos; G Cacho; P Escartín; J Ortiz-Berrocal
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

Review 6.  Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

7.  Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer.

Authors:  E el-Omar; I Penman; C A Dorrian; J E Ardill; K E McColl
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

Review 8.  Helicobacter pylori infection in functional dyspepsia.

Authors:  Hidekazu Suzuki; Paul Moayyedi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

9.  Gastrin activates nuclear factor kappaB (NFkappaB) through a protein kinase C dependent pathway involving NFkappaB inducing kinase, inhibitor kappaB (IkappaB) kinase, and tumour necrosis factor receptor associated factor 6 (TRAF6) in MKN-28 cells transfected with gastrin receptor.

Authors:  M Ogasa; Y Miyazaki; S Hiraoka; S Kitamura; Y Nagasawa; O Kishida; T Miyazaki; T Kiyohara; Y Shinomura; Y Matsuzawa
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

10.  Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.

Authors:  Chung-Wei Lee; Barry Rickman; Arlin B Rogers; Sureshkumar Muthupalani; Shigeo Takaishi; Peiying Yang; Timothy C Wang; James G Fox
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.